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Lipid model systemsCell-penetrating peptides (CPP) are able to efﬁciently transport cargos across cell membranes without being
cytotoxic to cells, thus present a great potential in drug delivery and diagnosis. While the role of cationic residues
in CPPs has been well studied, that of Trp is still not clear. Herein 7 peptide analogs of RW9 (RRWWRRWRR, an
efﬁcient CPP) were synthesized in which Trp were systematically replaced by Phe residues. Quantiﬁcation of
cellular uptake reveals that substitution of Trp by Phe strongly reduces the internalization of all peptides despite
the fact that they strongly accumulate in the cell membrane. Cellular internalization and biophysical studies
show that not only the number of Trp residues but also their positioning in the helix and the size of the hydro-
phobic face they form are important for their internalization efﬁcacy, the highest uptake occurring for the analog
with 3 Trp residues. Using CD and ATR-FTIR spectroscopywe observe that all peptides became structured in con-
tact with lipids, mainly inα-helix. Intrinsic tryptophan ﬂuorescence studies indicate that all peptides partition in
the membrane in about the same manner (Kp ~ 105) and that they are located just below the lipid headgroups
(~10 Å) with slightly different insertion depths for the different analogs. PlasmonWaveguide Resonance studies
reveal a direct correlation between the number of Trp residues and the reversibility of the interaction following
membranewashing. Thus amore interfacial location of the CPP renders the interactionwith themembranemore
adjustable and transitory enhancing its internalization ability.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
One of the major obstacles to the use of large therapeutic molecules
or imaging agents having intracellular targets is their low permeability
through biomembranes. One of the breakthroughs of the last 20 years
is the discovery of cell-penetrating peptides (CPP) asmolecules capable
of internalizing into cells in a receptor- and energy-independent way
and without being toxic to cells. Their great potential relies on the fact
that they can transport a great variety of cargoes into cells both in
terms of size and nature and some CPPs are even already used as drug
delivery vector (for a review, see [1]). Green & Loewenstein and Frankel
& Pabo discovered the ﬁrst CPP almost simultaneously in 1988 [2,3].TR-FTIR, Attenuated Total
etrating peptide; CD, Circular
ylphosphatidylcholine; DOPG,
ring; GAG, Glycosaminoglycan;
mellar vesicle; MALDI, Matrix-
r vesicle; MS, Mass spectrome-
l; PWR, Plasmon Waveguide
all Unilamellar Vesicles
s).They found that the Tat protein from HIV-1 was internalized into
cells and Vives et al., found in 1997 the minimal sequence that was
responsible for the protein internalization [4]. Following this ﬁnding,
penetratin was discovered in 1994 by the group of Alain Prochiantz
[5]. This is a peptide derived from the homeodomain of the Drosophila
homeobox Antennapedia and was shown to possess a good internaliza-
tion efﬁcacy. Since then a large number of Structure/Activity Relation-
ship studies have been performed both to study their membrane-
translocating capabilities and to design novel sequences with greater
efﬁcacy and better selectivity. Since the Tat peptide possesses a large
number of basic residues (6 Arg and 2 Lys on 13 residues) Wender
and Rothbard discovered that a polyarginine comporting 9 residues is
an efﬁcient CPP [6]. Futaki's group then synthesized oligoarginines of
different lengths (Rn with 6 b n b 12) and studied their internalization
efﬁciency [7]. They could determine that 8 Arg residues were sufﬁcient
to confer the polyarginine cell penetrating properties. Different deriva-
tives of penetratin have also been synthetized and it was observed
that the internalization was based neither on the chirality of the pep-
tide, nor its amphiphilicity or its secondary structure [5,8]. Regarding
the mechanisms implicated in their cellular internalization, it has been
generally accepted that both endocytosis and direct translocation
through the membrane are implicated in their uptake. The balance
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such as the nature and size of the CPP and its cargo, the nature of the
link between the two, the temperature at which internalization experi-
ments are conducted, the cell lines used, among other parameters
[9–12]. Electrostatic interactions between the positive charges in the
peptide and negative charges in the cell membrane surface have been
shown to be essential during theﬁrst stage of interactionwith themem-
brane. The presence of basic amino acids in the sequence has been well
studied and Arg residues have been reported to be especially important
for cellular internalization. It was shown that the uptake efﬁciency is at-
tributed to the type of bond formed between Arg and the lipid
headgroups rather than the charges presented to themembrane. Indeed
Arg can form bidentate hydrogen bonds that interact simultaneously
with phosphate moieties on multiple lipid headgroups while Lys resi-
dues can only form monodentate hydrogen bonds that interact with
the phosphate moiety on a single headgroup [13,14]. Guanidinium-
rich peptides also establish strong electrostatic interactions with nega-
tively charged heparan sulfate proteoglycans (HSPG) on the cell surface,
important as a ﬁrst recognition and their accumulation in the mem-
brane [15,16]. The presence of hydrophobic residues for internalization
has also been investigated. The substitution of the Trp48 and Trp56 by
Phe abolished totally the internalization of penetratin [17]. From these
studies, the Arg-rich CPP RW9 (RRWWRRWRR) was designed and de-
termined to possess very high cellular uptake efﬁciency [18]. Biological
studies on RW9 have revealed an important decrease in internalization
in GAG-deﬁcient cells evidencing that proteoglycans at the membrane
surface are important for its cellular internalization [19]. Biophysical
studies have shown its preferential interaction with anionic model
membranes corroborating biological studies on the importance of elec-
trostatic interactions between peptide and membranes. Previous stud-
ies on RL9 (RRLLRRLRR), an analog of RW9 where Trp residues were
replaced by Leu residues have shown that this peptidewas not internal-
ized into cells despite the fact that it accumulated in themembrane [19,
20]. At the same time, oligoargininepeptide (R9) possessing no aromatic
residues internalizes very well in eukaryotic cells at approximately the
same level as RW9 [19]. The main question addressed here is to under-
stand the role of the Trp in membrane translocation regarding the RW9
sequence. Therefore, we synthesized 7 peptides inwhich Phe systemat-
ically replaced Trp residues (RX9) (Table 1). The strategy was to keep
thehydrophobicity but specially the aromaticity of thehydrophobic res-
idues, because previous NMR studies on RW9 evidenced the existence
of π–cation interactions between certain Arg and Trp residues [19].
Quantiﬁcation of the total amount of internalized peptides (all intra-
cellular compartments included) shows that the replacement of all Trp
residues almost completely abolished the peptide internalization while
the substitution of 1 or 2 Trp strongly decreases their internalization
efﬁciency. To understand these differences in cellular internalization we
have decided to investigate the interaction of these peptides with lipid
membranes and therefore shed some light into their membrane crossing
and translocation. It should be noted that direct translocation through the
cellmembrane is just one of themanymechanisms used by CPPs to inter-
nalize, nonetheless a good understanding of CPP interaction with lipids is
important. For that we have used lipid model systems and different bio-
physical approaches in an attempt to correlate their cellular uptake andTable 1
Amino-acid sequences of the RX9 peptides used in this study.
Peptide sequence MW (Da) Charges (at pH 7)
RW9 Biotin(O2)-GGGG-RRWWRRWRR-NH2 1999 6
RFFF9 Biotin(O2)-GGGG-RRFFRRFRR-NH2 1882 6
RFFW9 Biotin(O2)-GGGG-RRFFRRWRR-NH2 1921 6
RWFF9 Biotin(O2)-GGGG-RRWFRRFRR-NH2 1921 6
RFWF9 Biotin(O2)-GGGG-RRFWRRFRR-NH2 1921 6
RFWW9 Biotin(O2)-GGGG-RRFWRRWRR-NH2 1960 6
RWWF9 Biotin(O2)-GGGG-RRWWRRFRR-NH2 1960 6
RWFW9 Biotin(O2)-GGGG-RRWFRRWRR-NH2 1960 6membrane direct translocationwith bilayer interaction. Since electrostat-
ic interactions were found to be important for the membrane interaction
of Arg-rich peptides with cellular membranes [see [21] for a review] we
have included anionic lipids in the model membranes used. Even though
anionic lipids are veryweakly present in eukaryotic cell membrane, espe-
cially in the outer leaﬂet, the few anionic lipids present (~2%) can have
their potential enhancedby assembling into domains, a property reported
to be induced by certain CPPs [22]. Although, the outer leaﬂet of healthy
eukaryotic membranes possesses almost no anionic lipids, important
electrostatic interactions between the CPPs and GAG can be established.
Often biophysicists have employed anionic lipids just tomimic the overall
anionic character of the cell membrane surface, which is also our
approach here. Additionally it should be noted that during certain
cellular dysfunctions such as when cells become tumoral or enter
apoptosis, the amount of anionic lipids in their outer leaﬂet (mostly
phosphatidylserine) increases up to 9%, rendering the cellular membrane
signiﬁcantly more anionic [23–26]. CD and ATR-FTIR were used to inves-
tigate the secondary structure of the peptides in contact with model
membranes to deﬁne if there was a correlation between their tendency
to adopt a secondary structure in the presence of lipids and their internal-
ization capacities. No direct correlation was found. Their cytotoxicity on
cells and effect on model membranes were explored. The replacement
of Trp by Phe induced no cytotoxicity or dye leakage although the pep-
tides bind and slightly perturb the membrane. The afﬁnity and insertion
depth of the peptides were studied by Plasmon Waveguide Resonance
and Trp ﬂuorescence and a correlation with their internalization capaci-
ties was established.
2. Materials & methods
2.1. Materials
All lipids were obtained from Avanti Polar Lipids (Alabaster, AL, USA).
The calcein and acrylamide were obtained from Sigma Aldrich.
Biotin(O2)-([1H]-G)4-RRFFRRFRR-NH2(RF9), Biotin(O2)-([1H]-G)4-
RRFFRRWRR-NH2(RFFW9), Biotin(O2)-([1H]-G)4-RRWFRRFRR-
NH2(RWFF9), Biotin(O2)-([1H]-G)4-RRFWRRFRR-NH2 (RFWF9),
Biotin(O2)-([1H]-G)4-RRFWRRWRR-NH2 (RFWW9), Biotin(O2)-
([1H]-G)4-RRWWRRFRR-NH2(RWWF9), Biotin(O2)-([1H]-G)44-
RRWFRRWRR-NH2(RWFW9) and Biotin(O2)-([2H]-G)4-RRFFRRFRR-NH2,
Biotin(O2)-([2H]-G)4-RRFFRRWRR-NH2, Biotin(O2)-([2H]-G)4-
RRWFRRFRR-NH2, Biotin(O2)-([2H]-G)4-RRFWRRFRR-NH2, Biotin(O2)-
([2H]-G)4-RRFWRRWRR-NH2, Biotin(O2)-([2H]-G)4-RRWWRRFRR-
NH2, Biotin(O2)-([2H]-G)4-RRWFRRWRR-NH2 were synthesized using
the Fmoc solid-phase strategy ([1H]-G and [2H]-G correspond to non-
deuterated and bi-deuterated glycine, respectively). The oxidation pro-
tocol of the biotin was as follows: 10 g of biotin was dissolved in 40 mL
of H2O2 (30% in H2O) and 120 mL of AcOHwas added. The mixture was
stirred at room temperature for fewhours and a precipitatewas formed.
The precipitatewasﬁltered,washedwith Et2O anddriedunder vacuum.
Oxidation efﬁciency of the biotin was checked by liquid-state NMR.
Biotin sulfone was coupled to the peptide under the same conditions
used for the amino-acid coupling. Peptides were puriﬁed by High
Performance Liquid Chromatography (HPLC), in a reverse phase
column (RP) C18 using H2O/CH3CN/TFA gradient. MALDI-TOF mass
spectrometry was used to characterize the peptides. To efﬁciently
remove the TFA counter-ion a simple method was used that consists
in lyophilizing the sample 3 times in the presence of 10mMHCl directly
replacing TFA counter-ionswith chloride ions [27]. A low concentration
of HCl was used to prevent peptide degradation. The removal of TFA
was followed by 19F-NMR.
2.2. Cell culture
Wild type Chinese hamster ovary CHO-K1 (WT) cells were cultured
in Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
Table 2
Viability assays (in percentage) for the RX9 peptides for a peptide concentration of 5 μM
and with different incubation times. The experiments have been performed twice and
each time in triplicate.
1 h 6 h 24 h
RFFF9 104 ± 13 65 ± 10 105 ± 2
RFFW9 104 ± 25 66 ± 10 90 ± 5
RWFF9 91 ± 28 62 ± 9 78 ± 8
RFWF9 103 ± 23 57 ± 9 78 ± 5
RFWW9 85 ± 14 51 ± 8 76 ± 4
RWWF9 80 ± 20 51 ± 8 76 ± 20
RWFW9 75 ± 6 54 ± 8 77 ± 9
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(100,000 IU/L), and amphotericin B (1 mg/L) in a humidiﬁed
atmosphere containing 5% CO2 at 37 °C.
2.3. Cell viability assays
Cell viability was measured using the Dojindo Cell-Counting Kit 8
based on the reduction of a reagent into a colored product by viable
cell dehydrogenases. CHO-K1 cells were seeded in a 96-well plate
1 day before treatment (4000 cells per well). Cells were treated with
5 μM, 10 μM, 20 μM or 50 μM peptide for 1 h, 6 h and 24 h. Untreated
cells were deﬁned as living cell control (negative control) and 0.3%
Triton X-100 as maximum cytotoxicity (positive control).
2.4. Cellular uptake and quantiﬁcation of membrane-bound peptide
Cellular uptake was quantiﬁed using the method described by
Burlina et al. [28]. In this protocol, the studied peptides bear a tag
composed of four glycine residues together with a biotin moiety for
puriﬁcation purposes. After 1 h incubation of 10 μM peptide and wash-
ing, a protease is added (0.05% Pronase in Tris–HCl buffer, 100 mM
pH 7.5) in order to detach the cells and to degrade all the non-
internalized or membrane-bound peptides. This avoids overestimating
the quantity of internalized peptide due to the presence of peptides
attached to the outer leaﬂet of the membrane. The cells are then lysed
(0.3% Triton, 1 M NaCl) and boiled and the cell lysate is incubated
with streptavidin-coated magnetic beads to extract the peptide from
the lysate. This protocol gives access to the total amount of intact inter-
nalized peptide. For quantiﬁcation of total cell-associated CPP (non-
washable membrane-bound + internalized peptide), the same experi-
mental conditions were used except that no protease was added and
the cells were directly lysed. The peptides are eluted from the
streptavidin-coated magnetic beads with HCCA matrix and spotted on
the MALDI plate. Mass spectrometry is not a quantitative method per
se, therefore an internal standard is added to the lysis solution. This
standard peptide has the same sequence as the one to quantify except
that it bears a tag composed of four bi-deuterated glycine residues
instead of four glycine residues. This allows the quantiﬁcation of inter-
nalized and membrane-bound peptide. The samples were analyzed by
MALDI-TOF MS (positive ion reﬂector mode) on a Voyager DEPRO
mass spectrometer (Applied Biosystems).
2.5. Preparation of liposomes
All liposomes were prepared by initially dissolving the appropriate
amount of phospholipids, to obtain the desired concentration, in chloro-
form and methanol to ensure the complete mixing of the components.
A lipid ﬁlm was then formed by removing the solvent using a stream
of N2 (g) followed by 3 h under vacuum. To formMLVs the dried lipids
were dispersed in buffer (either 10mMTris, 150mMNaCl, 2 mMEDTA
or 10mMphosphate buffer depending on the techniqueused) and thor-
ough vortexed. To form LUVs the MLV dispersion was run through ﬁve
freeze/thawing cycles and passed through a mini-extruder equipped
with two stacked 0.1 μm polycarbonate ﬁlters (Avanti, Alabaster, AL).
SUVs were prepared by tip sonication after direct hydration of the
lipid ﬁlm.
2.6. Dynamic light scattering experiments
The experiments were performed using the Zetasizer Nano
(Malvern) system with an ALV Laser goniometer, which consisted of a
35 mW HeNe linear polarized laser with a wavelength of 632.8 nm
and an ALV-5000/EPP Multiple Tau Digital correlator with 125 ns initial
sampling time. The measurements were carried out at 173°. All
measurements were performed at room temperature (25 °C) in
phosphate buffer. To get an insight into the inﬂuence of the peptideson LUV integrity, 40 μL of a 1 mg/mL LUV solution was analyzed by
DLS, followed by the addition of a small volume of peptide (1 mM) to
the LUV suspension to the desired P/L ratio (1/100, 1/50, 1/25, 1/10)
and particle size again analyzed, immediately.2.7. Circular dichroism experiments
CD data were recorded on a Jasco J-815 CD spectrophotometer with
a 1 mm path length. Far-UV spectra were recorded from 180 to 270 nm
with a 0.5 nm step resolution and a 2 nm bandwidth at 37 °C. The scan
speed was 50 nm/min (0.5 s response time), and the spectra were
averaged over 8 scans. CD spectra were collected for all the peptides
in phosphate buffer with and without liposomes at different P/L ratios
(1/50, 1/25, 1/10). For each sample, the background (buffer) was auto-
matically subtracted from the signal. Spectra were smoothed using a
Savitzky–Golay smoothing ﬁlter. Spectra were deconvoluted using the
software CDFriend previously developed in our laboratory (S. Buchoux,
not published).2.8. ATR-FTIR spectroscopy
Small Unilamellar Vesicles (SUV) composed of DOPC or DOPC:DOPG
(4:1) were prepared in a solution of D2O. SUVs were burst on a germa-
nium ATR crystal to form a single bilayer which is controlled by the
measurement of the absolute IR intensity. ATR spectra were recorded
on a Nicolet 6700 spectrometer ThermoScientiﬁc equipped with a
MCT detector cooled at 77 K. Since ATR spectroscopy is sensitive to
the orientation of the structures, spectra were recorded with parallel
(p) and perpendicular (s) polarizations of the incident lightwith respect
to the ATR plate [29,30]. 400 scans were recorded at a resolution of
4 cm−1. All the orientation information are then contained in the
dichroïc ratio RATR = Ap/As, where Ai represents the absorbance of
the considered band at p or s polarization of the incident light.
The resulting spectra were analyzed with an algorithm based on a
second-derivative function and a self-deconvolution procedure
(GRAMS and OMNIC softwares, ThermoFisher Scientiﬁc) to determine
the number and wavenumber of individual bands within the spectral
range 1600–1690 cm−1. The amide I band of each spectrum could be
ﬁtted by four bands assigned to the vibration of amide I involved in
four different secondary structures (Fig. S2). Vibrational assignments
of the infrared band components in the amide I region were made
according to Goormaghtigh et al. [29,30]. The ﬁt was obtained with a
mixed Lorentzian (25%)–Gaussian (75%) band proﬁle and width at
half-height included between 20% and 25%. The relative contributions
of the different bands were determined from the ﬁt results obtained
for the amide I band. The amount of each secondary-structure element
is given as a percentage (Table 2) and is determined by dividing the
integral intensity of one amide I band component by the total intensity
of all amide I band components. The standard error does not exceed
1.5%. For all spectra, ﬁt results correspond to a local minimum at the
end of the iteration procedure.
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Calcein-containing LUVsweremade using the same protocol used to
make regular LUVs, except for the hydration step of the lipid ﬁlms that
was made with Tris buffer containing 70 mM calcein. The protocol to
prepare calcein-loaded vesicles was the same as previously described
by Jobin et al. [31]. For the assay, the lipid concentration was set at
1 μM and peptide concentration was allowed to vary from 10 nM to
100 nM (P/L ratio of 1/100 to 1/10 respectively). All measurements
were performed on 96-well microplates using a Perkin Elmer LS55
spectrometer (Buckinghamshire, UK). Data were collected every min-
ute at room temperature using a λexc at 485 nm and λem at 515 nm
with an emission and excitation slit of 2.5 nm.
The ﬂuorescence intensity at the equilibrium was measured after
1.5 h. At the end of the assay, complete leakage of LUVs was achieved
by adding 10 μL of 10% Triton X-100 solution dissolving the lipid mem-
brane without interfering with the ﬂuorescence signal. The percentage
of calcein release was calculated according to the following equation:
% calcein leakage ¼ Ft−F0
Ff−F0  100 ð1Þ
where the percent of calcein leakage is the fraction of dye released
(normalizedmembrane leakage), Ft is themeasuredﬂuorescence inten-
sity at time t, and F0 and Ff are respectively the ﬂuorescence intensities
at times t = 0, and after ﬁnal addition of Triton X-100, respectively. A
dilution correctionwas applied on the ﬂuorescence intensity after injec-
tion of the Triton X-100. Each experiment was repeated three times.
2.10. Fluorescence spectroscopy measurements
2.10.1. Nernst partition coefﬁcient experiments
Peptide–phospholipid interactions were studied by monitoring the
changes in the Trp ﬂuorescence emission spectra of the peptides upon
addition of LUVs. Intrinsic Trp ﬂuorescence of the peptides was
measured before and after addition of different amounts of phospholipid
vesicles to a 0.5 μM peptide solution. Trp ﬂuorescence was measured at
room temperature on a Spex Fluoromax-4 (Horiba) spectroﬂuorometer.
Emission spectra were recorded between 300 and 500 nm with an
excitation wavelength of 280 nm, slit widths of 5 nm for excitation
and 10 nm for emission. Peptide–lipid binding was determined from
the quenching of the intrinsic Trp ﬂuorescence intensity of the peptides
upon addition of LUVs. The maximum ﬂuorescence intensity was
plotted vs. the added lipid concentration and ﬁtted using the simple
partition model (2), the self-quenching model (3) and the three-state
partition model well described by Melo & Castanho [32]. The data
were analyzed using Origin.
I
Iw
¼ 1þ KpγL L½ IL=Iw
1þ KpγL L½ 
ð2Þ
I
Iw
¼ 1þ KpγL L½ IL=Iw
1þ KpγL L½  þ k2KpIL
þ 1
1þ KpγL L½ 
ð3Þ
where [L] is the total phospholipid concentration available for the
peptide to interactwith, Kp is theNernst partition constant, k2 is propor-
tional to the ratio between the bimolecular self-quenching rate and the
radiative decay rate, γL is the phospholipids molar volume, which is
0.763M−1 for the lipid used in this study. IL and IW are the ﬂuorescence
intensities themixture would display if all the peptidewas in the lipidic
or aqueous phase, respectively. IW can be obtained from the measure-
ment of I in the absence of lipid; IL is a limit value of ﬂuorescence
intensity as [L]→ ∞ and is determined as a system parameter together
with Kp.2.10.2. Brominated lipid quenching experiments
Depth-dependent ﬂuorescence quenching of tryptophan was
performed in LUVs composed of DOPC, DOPC:DOPG 4:1, and either
(6,7)-, (9,10)-, or (11,12)-BrPC at molar ratios of 70:30 with DOPC:
BrPC and 50:20:30 with DOPC:DOPG:BrPC. Fluorescence intensities in
the absence of quencher (F0) were measured in DOPC and DOPC:
DOPG (4:1) vesicles. Spectra were recorded between 300 and 500 nm
with an increment of 1 nm and an integration time of 0.1 s, using an
excitation wavelength of 280 nm. The P/L molar ratio was 1:50 and
the peptide concentration was 0.5 μM (for RW9, RWFF9, RFWF9 and
RWWF9) and 0.8 μM (for RFWW9). Data were corrected for vesicle
background, and the total intensity was calculated as the sum of all
measured points in each spectrum. Depth-dependent ﬂuorescence
quenching proﬁles (DFQPs) were ﬁtted to data in Matlab using the
Distribution Analysis (DA) method [33,34] as well as the parallax
method (PM) [35–38].
DA : ln
F0
F hð Þ
¼ S
σ
ﬃﬃﬃﬃﬃﬃ
2π
p exp − h− hmð Þ
2
2σ2
" #
ð4Þ
PM : ln
F0
F hð Þ
¼ πC R2c− h−hmð Þ2
h i
ð5Þ
In the equations above, F0 is theﬂuorescence intensity in the absence
of quencher, F(h) is the intensity in the presence of quencher at the dis-
tance h (Å) from the bilayer center, and hm is the average insertion
depth of the tryptophan residues. In DA the DFQP data are ﬁtted with
a Gaussian function where σ denotes the dispersion, which is related
to the in-depth distribution of the tryptophan chromophores, and S is
the area under the quenching proﬁle, which is related to the
quenchability of the tryptophan moiety. The Parallax Method ﬁts data
to a truncated parabola, and Rc is the radius of quenching. Average
bromine distances from the bilayer center (h) were taken to be 11.0,
8.3, and 6.5 Å for (6,7)-BrPC, (9,10)-BrPCand (11,12)-BrPC, respectively
[38].
2.10.3. Acrylamide quenching experiments
Peptide–lipid interactions are accompanied by changes in the acces-
sibility of the peptides to aqueous quenchers of Trp ﬂuorescence. Acryl-
amide quenching experiments were carried out on a 0.5 μM peptide
solution in the absence or presence of LUVs by addition of aliquots of
4 M acrylamide solution. The peptide/lipid mixtures (P/L molar ratio
of 1/50) were incubated for 15 min at room temperature prior to the
measurements. The excitation wavelength was set to 295 nm instead
of 280 nm to reduce absorbance by acrylamide. Fluorescence intensities
were measured after addition of quencher at room temperature. The
quenching constants were obtained from the slope of the Stern–Volmer
plots of F0/F vs. [quencher], with F0 and F as the ﬂuorescence intensities
in the absence and presence of quencher, respectively. The normalized
accessibility factor (naf) was calculated in comparison with the Ksv for
each peptide in buffer.
2.11. Plasmon Waveguide Resonance measurements
Experiments were performed on a beta PWR instrument from
Proterion Corp. (Piscataway, NJ) that had a spectral angular resolution
of 1 mdeg. The technique used to form supported bilayers was the
same that the one previously described by Salamon et al. [39–41].
Data were ﬁtted (GraphPad Prism) through a hyperbolic saturation
curve providing the dissociation constants. It should be noted that
since concomitantly with the binding process other processes, such as
membrane reorganization and solvation occur, the dissociation
constants correspond to apparent dissociation constants. In order to
test for binding reversibility following peptide binding at saturating
concentrations, the PWR cell sample was washed twice, by ﬂowing
Fig. 1. (A) MALDI-TOF MS quantiﬁcation of RX9 and RW9 internalization in 1 million
CHO-K1 cells after peptide incubation for 1 h at 37 °C. (B) Membrane-bound peptide
quantiﬁcation on CHO-K1 cells (1 million) determined by mass spectrometry
(MALDI-TOF) at 37 °C. Signiﬁcance was tested using a Student t test: ns: p N 0.05;
*0.01 b p b 0.05; **0.01 b p b 0.001; ***p b 0.005.
597M.-L. Jobin et al. / Biochimica et Biophysica Acta 1848 (2015) 593–602buffer through the cell. Following that the spectra were acquired for
both polarizations. A comparison of the resonance angles before and
after washing gives information about the reversibility in the P/L
interaction.
3. Results & discussion
3.1. Effect of the peptides on the cell viability
The cell viability was tested with all RX9 peptides and was ﬁrst
studied to investigate whether the replacement of Trp residues changes
their cytotoxicity (Table 2). The cell viability was measured on CHO-K1
cells using the CCK8 test providing the rate of viable cells. Concentra-
tions varied between 5 and 50 μM and peptides were incubated for 1,
6 and 24 h at 37 °C. None of the peptides has shown any signiﬁcant
cytotoxicity at these concentrations at 1 h (which corresponds to the
incubation time used to quantify cellular uptake). However we noticed
a decrease of the cell viability for longer incubation time (6 h and 24 h).
This demonstrates that the replacement of Trp by Phe residues in the
sequence affects the cytotoxicity of the peptides.
3.2. Quantiﬁcation of cellular uptake and membrane-bound peptide
Quantiﬁcation of cellular uptake of each peptide was investigated by
a protocol already published that uses MALDI-TOF mass spectrometry
as the analytical technique [28]. The experiments were performed
with CHO-K1 cells at 37 °C, a temperature at which both endosomal
and cytosolic peptides were quantiﬁed and at which peptides can
enter through both endocytosis and direct translocation [42,43]. The re-
sults show that all RX9 peptides are much less internalized (~1 pmol or
less) than RW9 (~10 pmol), about a ten-fold decrease (Fig. 1A). The
least internalized peptide (only ~0.2 pmol) is observed for the analog
containing no Trp residues (RF9). The analogs containing 1 or 2 Trp
residues are slightly more internalized (~1 pmol) than RF9 but show
no difference between them. The results indicate that the presence of
Trp residues in RW9 analogs is important for their cellular internaliza-
tion. Since the ﬁrst contact between the peptide and the cell is through
the cell membrane, quantiﬁcation of membrane-bound peptide was
performed. Overall, the results show that RX9 peptides accumulate in
the membrane in the same extent as RW9 (~250 pmol) (Fig. 1B).
Membrane accumulation at 4 °C provides similar results (data not
shown). In terms of the two extreme behaviors, the peptide RWFF9
accumulates themost in themembrane (~450 pmol), while the peptide
RFWW9accumulates the least (~100 pmol). These results show that the
presence of Trp residues is important for RX9 cellular internalization. No
correlation exists between the amount of membrane-bound and that of
internalized peptide in the RX9 series.
From the cellular uptake results we have selected for further studies
5 peptides that appeared to be themost representative of the RX9 series,
notablywith variable number of Trp residues and signiﬁcant differences
in internalization capacities. We have therefore chosen the peptide
without Trp residues (RF9), 2 peptides containing 1 Trp (RFWF9 and
RWFF9) and 2 peptides with 2 Trp (RFWW9 and RWWF9). Biophysics
experiments aimed at characterizing their interaction with lipid
membranes in an attempt to correlate that with the differences in
terms of cellular uptake efﬁcacy were performed on the 5 selected
peptides (described in the next sections).
3.3. Peptide secondary structure
As with RW9, the CD spectra of the RX9 peptides were strongly
affected by the π–π stacking occurring between aromatic residues [19].
In the case of RF9, RFWW9 and RWWF9 (3 Phe and 1 respectively), a
negative band around 230 nmwas also observed that prevented proper
spectral decomposition (Fig. S1). This band is negative in the case of the
RWWF9 and positive in the case of the RFWF9 as it depends on theorientation of the aromatic residues. Peptides with 2 Phe (RFWF9 and
RWFF9) gavemore interpretable results as no absorbance was observed
at 230 nm allowing data decomposition and secondary structure deter-
mination. In buffer and in the presence of zwitterionic lipids, the
peptides are in random coil conformationwith a smallα-helix contribu-
tion (~10%; Fig. S1). In the presence of anionic lipids, 2 negative bands at
208 and 222 nm are observed indicating α-helix structuration (~20%;
Fig. S1). Helical structuration in the presence of anionic liposomes was
also observed in the case of RW9 [19]. Moreover a preferential π–cation
interaction between residues Arg8 and Trp4 and Trp7 was evidenced by
solution NMR by Walrant et al. [19]. Since we replaced Trp4 and Trp7
by Phe in some cases, those interactions might have been affected.
Indeed, the most internalized peptide for the RX9 series is RFWW9,
which retains Trp4 and Trp7 and thus preserves these interactions.
Therefore π–cation interactions seem to affect peptide internalization.
This is to be expected since such interactions partially mask the charge
of the peptide allowing a less energetically unfavorable membrane
crossing.
The results indicate that the replacement of some Trp by Phe resi-
dues does not change the secondary structure of RX9 in interaction
with lipids and so the secondary structure upon lipid contact is not
directly correlated to the internalization. The possibility of a correlation
between the capacity of a CPP to adopt a particular secondary structure
and to translocate is so far not clear in the literature. For example in the
case of penetratin it has been shown that α-helical structure is not
necessary for its internalization [8,44].
The secondary structure of the peptides in contact with lipids was
also investigated by ATR-FTIR spectroscopy to avoid this issue caused
by the aromatic residues (Table 3). We have found that the secondary
Table 3
RX9 peptide secondary structure percent determined by ATR-FTIR spectroscopy.
*RC: random coil.
Buffer DOPC DOPC:DOPG
Peptides RC* α-Helix β-Sheet β-Turn RC* α-Helix β-Sheet β-Turn RC* α-Helix β-Sheet β-Turn
RFFF9 19 35 32 14 24 37 11 28 20 41 27 12
RWFF9 29 41 11 19 28 46 12 14 30 28 31 11
RFWF9 22 33 19 26 19 34 20 27 32 33 28 7
RFWW9 52 26 7 15 23 38 27 12 29 37 26 8
RWWF9 30 31 22 17 25 38 22 15 31 40 18 11
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to a mixture of peptides adopting different secondary structures. Thus
we were unable to perform spectral decomposition and determine
with certainty the type and amount of each secondary structure.
However we observed a marked increase in helical content in the
presence of membranes, especially those containing anionic lipids.3.4. Peptide effect onmembrane supramolecular organization and integrity
Dynamic light scattering (DLS) experiments were performed in
order to investigate the inﬂuence of the peptides on liposome size and
distribution. Measurements were acquired in the absence and presence
of peptide and at different P/L ratios. Table S1 presents the variation in
size distribution of liposomes composed of DOPC, DOPG and DOPC:
DOPG (4:1 mol:mol) and for a P/L ratio of 1/50. In the case of DOPC
the size of the liposomes was not signiﬁcantly modiﬁed by peptide
addition but the size of anionic liposomes (DOPG and DOPC:DOPG)
increased importantly (up to 100 nm size increase) in the presence of
the peptides. This shows that aggregation or fusion of anionic liposomes
is induced by peptide addition. The same observation was reported by
Walrant et al. on the effect of RW9on anionic lipids by following changes
in turbidity [19]. No signiﬁcant differences among the RX9 analogswere
observed indicating that lipid interactions are mostly driven by electro-
static forces and therefore by the number of Arg residues which is the
same for all peptides.
Calcein leakage experimentswere performed to investigatewhether
RX9 peptides perturbed liposomemembrane integrity (e.g. pore forma-
tion). In the case of anionic liposomes almost no leakage was observed
(less than 1%) following 1 h peptide incubation at a P/L ratio of 1/50,
meaning that the membrane integrity was not affected by the addition
of the RX9 peptides. In the case of zwitterionic liposomes the leakage
was slightly higher (below 5%) indicating that RX9 peptides slightly
perturbed these liposomes (Table S2). We have observed that the
leakage was similar (b5%) for all peptides and at all P/L ratios (1/100
to 1/10; data not shown) so we assumed that this could result from a
saturation of the bilayer surface by the peptide that induced a slight
leakage. Overall, the results indicate that the peptides donot signiﬁcantly
perturb the membrane integrity (no pore formation), which are in
agreement with cell viability results.Table 4
Partition coefﬁcients (Kp) of the RX9 peptides with increasing concentration of liposomes
(from 2.5 μM to 200 μM) at constant peptide concentration (0.5 μM). The experiments
have been done in duplicate at room temperature.
Kp (.105)
DOPC DOPC/DOPG (4:1) DOPG
RW9 2.0 ± 0.8 3.8 ± 0.2 1.5 ± 0.6
RWFF9 4.6 ± 0.5 3.1 ± 0.5 1.6 ± 0.2
RFWF9 2.15 ± 0.05 1.765 ± 0.005 1.88 ± 0.07
RFWW9 3.4 ± 0.7 1.77 ± 0.06 2.51 ± 0.07
RWWF9 3.0 ± 0.5 0.9 ± 0.6 1.4 ± 0.23.5. Peptide interaction and partitioning with model membranes
The intrinsic Trp ﬂuorescence of the peptides was used to character-
ize the partitioning of the RX9 peptides with model membranes. The
Nernst partition coefﬁcient (Kp) was calculated at a constant peptide
concentration from the ﬂuorescence intensity (I) vs. lipid concentration
([L]) plots using the titration method already described [45,46]. The
coefﬁcient Kp is the ratio between membrane-bound and aqueous
phase peptide concentrations. For all lipid systems the Kp obtained
was in the range of 105 evidencing the importance of electrostatic
recognition in P/L interaction [47] (Table 4). This is consistent with the
fact that RX9 peptides are positively charged at physiological pH (6+)
(Table 1) and thus can establish important electrostatic interactionsFig. 2. Partition curves of RW9 (A) and RFWW9 (B) peptides in the presence of liposomes.
The peptide concentration used was 0.5 μMand the lipid stock concentration was 0.1 mM
and 1 mM. The data were ﬁtted with Eq. (2) for DOPC and DOPG curves in the case of
RFWF9, RFWW9 and RWWF9, Eq. (3) was used to ﬁt the DOPC:DOPG (4:1 mol:mol)
curves and the three-state model equations were used to ﬁt DOPG curves of RW9 and
RWFF9.
Fig. 3. Normalized accessibility factor (naf) of the RX9 peptides determined from the
Stern–Volmer constants normalized relatively to the KSV in buffer. The bars represent
the naf for buffer (white), DOPC (black), DOPG (red) and DOPC:DOPG (4:1 mol:mol)
(blue) liposomes. Experiments were done in triplicate at room temperature.
Fig. 4. Interaction of the peptides with the bilayer monitored by PWR. (A) Shifts in the
resonance minimum upon interaction of increasing concentrations of peptide with the
bilayer for p- and s-polarization (black curve and gray curve respectively).
(B) Dissociation constants (KD) determined with PWR for peptide interaction with
EggPC (black bars) and EggPC:POPG (4:1 mol:mol) (blue bars) supported bilayers. The
experiments were done in triplicate at room temperature.
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partition of the different peptides was comparable independently of the
lipid composition.
Even though the Kp among theRX9 and RW9peptideswas the same,
partition curves were different depending on liposome composition. In
the case of DOPC ﬂuorescence intensity of the peptides decreased upon
lipid contact with a hyperbolic behavior but with no shift in the
maximum wavelength ﬂuorescence (Fig. 2).
This results from dynamic quenching of the Trp ﬂuorescence follow-
ing the interaction of the peptides with the lipid polar headgroups. The
absence of shift in the maximum wavelength ﬂuorescence upon lipid
contact suggests that the peptide might be adsorbed to the membrane
with the same hydrophilic environment as when in solution and there-
fore it is not deeply inserted in the hydrophobic core.
This behavior was slightly different in the presence of liposomes
containing DOPG (DOPC:DOPG 4:1). The same decrease in ﬂuorescence
intensity was observed at low lipid concentrations and then at a higher
lipid concentration a hyperbolic increase appeared along with a blue
shift of ~10 nm in the maximum ﬂuorescence intensity (Fig. 2). This
behavior has already been reported and results from peptide self-
quenching upon bilayer insertion [32,48]. The Trp inserts more deeply
in the bilayer at the lipid acyl chain region changing its environment
to a more hydrophobic one. This different behavior in terms of Trp
ﬂuorescence in the presence of anionic lipids in themembranewas con-
ﬁrmed with experiments on pure DOPG liposomes where a three-step
processwas observed (Fig. 2A). In theﬁrst phase, at low lipid concentra-
tions, the maximum ﬂuorescence intensity increases but no blue shift
appears indicating that the peptide interacts with the membrane
without inserting deeply in the hydrophobic core. This ﬁrst superﬁcial
contact might be the consequence of strong electrostatic interactions
between the Arg and the negative charges of DOPG. In the second
phase, at higher lipid concentrations, a large blue shift is observed
(~20 nm) with a small decrease in intensity for certain peptides (RW9
and RWFF9) followed by an increase until a plateau is reached
(Fig. 2A). For the peptides RFWF9, RFWW9 and RWWF9, the curve
proﬁle is only hyperbolic. This increase in ﬂuorescence maximum is
due to solvent effects, which increase Trp quantum yield that is also
evidenced by the blue-shift. This corroborates with a deep insertion of
the peptide into the bilayer with the Trp residues oriented toward the
hydrophobic core of the membrane. These two-stage membrane inter-
action and insertion were already proposed by Walrant et al. for RW9,
demonstrating that Arg residues act as anhinge bymeans of, in an initial
stage, electrostatic interactions with the anionic lipids and then a
deeper Trp insertion in a second stage [49].
The Kp observed was similar among the RX9 peptides and more
surprisingly for the different lipid systems. This indicates that the pro-
portion of membrane-bound peptide, relative to the free one, is the
samewhatever themembrane composition but the kinetics and afﬁnity
of interaction might be different (this is further described below). The
number and position of Trp does not seem to affect the partitioning of
the peptides in the membrane indicating that electrostatic interactions
play a major role in this process.
Based on the blue shift observed with anionic liposomes we could
determine a “half-binding” corresponding to the concentration of lipids
necessary to reach 50% of the blue-shift (Fig. S2). The half-binding was
much lower with DOPG than with DOPC:DOPG LUVs. This conﬁrms
that peptide interaction with the membrane is enhanced in the pres-
ence of anionic lipids. To further investigate the insertion of thepeptides
into liposomes of different compositions, we have calculated the Stern–
Volmer constant (KSV) by doing acrylamide-quenching experiments
(Fig. 3).We havenormalized the results to theKSV in the buffer to obtain
the normalized accessibility factor (naf). This allows us to compare the
results obtained among the different peptides. The results show that
Trp residues of all peptides upon contact with zwitterionic liposomes
are almost totally exposed to the buffer (60 to 90% of accessibility).
They are more buried in the presence of partially anionic liposomes(20 to 30 % of accessibility) and almost completely with pure DOPG
liposomes (10 to 20% of accessibility). No signiﬁcant differences were
observed among the RX9 and RW9 peptides with this technique.
Plasmon Waveguide Resonance (PWR) was used to study the
afﬁnity of the RX9 for zwitterionic and anionic lipids and the effect in
the membrane organization. Upon peptide addition a decrease in the
resonance angle was observed for both p- and s-polarization indicating
Table 5
Average insertion depth of the peptides in DOPC:DOPG (4:1) LUVs determined by the
Distribution Analysis (DA) and Parallax Methods (PM) together with the respective
method ﬁtting parameters. The experiments have been done on in triplicate at room
temperature.
DA PM
hm (Å) σ (Å) S hm (Å) Rc (Å)
RW9 10.4 ± 0.9 5.8 ± 1.2 1.3 ± 0.5 10.2 ± 0.7 8.2 ± 1.4
RWFF9 9.7 ± 0.5 2.6 ± 0.4 0.6 ± 0.1 9.9 ± 0.8 4.8 ± 1.2
RFWF9 9.9 ± 0.2 2.3 ± 0.4 0.3 ± 0.1 10.6 ± 0.9 5.1 ± 0.4
RFWW9 11.2 ± 1 2.9 ± 1 0.7 ± 0.5 12.7 ± 0.1 7 ± 1
RWWF9 11 ± 0.8 3.8 ± 1.2 0.9 ± 0.6 11.1 ± 0.5 6.5 ± 1.3
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(Fig. 4). This might be due to a detergent effect of the peptide leading to
partial removal of lipid from themembrane or to a reorganization of the
lipids induced by the peptide leading to an overall higher surface area
occupied by each lipid.
By following the resonance position shifts upon incremented
addition of peptide and ﬁtting with a hyperbolic function, KD values
were obtained (see Materiel & methods for details). An afﬁnity in the
nanomolar range was observed for all peptide interactions and both
membrane compositions; however the afﬁnity was slightly higher in
the case of anionic lipids (KD ~ 1 nM for zwitterionic lipids and
~0.2 nM for anionic lipids; Fig. 4B). This agrees well with the results
obtained by ﬂuorescence studies (KSV and “half-binding” constants)
presented previously, indicating enhanced interaction and insertion
with anionic lipids. After reaching peptide saturation (plateau), the
lipid membrane was washed by ﬂowing buffer through the cell in
order to test whether peptide binding and effect on membranes were
reversible. We observe a correlation between the number of Trp
residues and the reversibility of the interaction, the lower the number
of Trp residues, the less reversible being the interaction (Fig. 5). We
interpret this observation as follows: Phe residues being more hydro-
phobic than Trp allows the peptide to be more deeply inserted in the
membrane and therefore in a less reversible and a more permanent
manner. Washing the membrane in the case of RW9 leads to an almost
complete recovery of the membrane signal obtained before peptide
addition (almost completely reversible binding). The data allow us to
conclude that the aromaticity of the amino-acids is important for the
peptide membrane translocation but a high hydrophobicity of such
residues prevents the peptide translocation due to a deeper and/or
more irreversible lipid interaction.3.6. Peptide insertion in the membrane
The studies of tryptophan ﬂuorescence quenching by brominated
lipids provide information about the membrane insertion level of the
peptides. The Trp insertion depth from the bilayer center for the RX9
analogs was obtained for DOPC/DOPG (4:1) LUVs. The average Trp
insertion level of the RX9 and RW9 is around 10–11 Å from the mem-
brane center, according to both Distribution Analysis (DA) and Parallax
Method (PM) analysis (Table 5; Fig. S3), thus Trp residues are located
just below the lipid polar headgroups. Overall the peptides with 2 Phe
residues are slightly more inserted in the bilayer (~9 Å) than the oneFig. 5. Percentage of “washing-resistant” or irreversible membrane-bound peptide after a
washing step of the PWR cell (2 mL) represented as a function of the number of Trp and
Phe residues.with 1 Phe (~11 Å). This is consistent with the reversibility of the bind-
ing of the peptides observed with PWR.
The study shows that the higher hydrophobicity of the Phe plays an
important role in peptide insertion and depth in anionic membranes. If
one assumes that the peptides are mostly structured in helical confor-
mation their backbone should be located around 16 Å from the bilayer
center. Molecular dynamic simulation (MDS) data obtained on RW9
show an insertion depth of the peptide backbone of 14 Å from the bilay-
er center. The results are thus comparable, the small difference observed
can arise from the time range differences between the two experiments
that are much longer in these studies than in MDS.We could not obtain
results with DOPC liposomes with the brominated lipid quenching
experiments. This could be due to the fact that with DOPC the peptides
interact more superﬁcially and with slightly smaller afﬁnity than with
anionic liposomes.
The peptide effect on the membrane lipid orientation and organiza-
tion was examined by polarized ATR-FTIR experiments (Table 6). Such
experiments allow one to calculate the dichroic ratio (RATR = Ap/As)
relative to the symmetric CH2 vibration mode (νs CH2) of the lipid
chains (around 2853 cm−1) and how that was affected by the peptides.
Such ratio provides information about the peptide effect on the lipid
chain ordering and orientation. We have observed a slight increase in
the RATR of DOPC lipids in presence of most of the RX9 peptides (except
RWFF9) corresponding to a slight disorganization of the lipid chains. On
the contrary a slight decrease of the RATR was observed with anionic
membranes (DOPC:DOPG 4:1) indicating that the peptide further
organized these lipids. This probably results from the fact that peptide
interactionwith anionic lipids leads to a decrease of the repulsive forces
between the lipid headgroups and thus an increase in ordering and
packing of the membrane. This correlates well with calcein leakage
experiments in which no leakage was observed with anionic lipids
and a slight leakage was observed with zwitterionic lipids. However
no signiﬁcant differenceswere evidenced among theRX9peptides lead-
ing us to conclude thatmembrane perturbation induced by the peptides
is not a property that could explain the observed differences in cellular
internalization.
4. Conclusion
Herein we have investigated the role of Trp residues in the cellular
internalization and membrane interaction properties of the RW9 CPP.
While arginine role has been thoroughly investigated and establishedTable 6
Dichroïc ratio (RATR) of symmetric carbonyl lipid stretching (νs CH2) around 2853 cm−1
for DOPC and DOPC:DOPG (4:1) in the absence and in the presence of 5 nmol of RX9
peptides.
Peptides DOPC + peptide DOPC:DOPG + peptide
RFFF9 1.45 ± 0.1 1.62 ± 0.08 1.4 ± 0.09 1.42 ± 0.03
RWFF9 1.53 ± 0.1 1.47 ± 0.1 1.5 ± 0.06 1.35 ± 0.1
RFWF9 1.44 ± 0.1 1.5 ± 0.1 1.41 ± 0.05 1.33 ± 0.05
RFWW9 1.39 ± 0.07 1.46 ± 0.01 1.39 ± 0.07 1.38 ± 0.05
RWWF9 1.28 ± 0.09 1.4 ± 0.1 1.4 ± 0.04 1.37 ± 0.09
Fig. 6.Hydrophobic plot of RW9, RL9, RW16 and RX9 analogues. The abscissa gives the he-
lical hydrophobicmoment (bμHN) of each peptide and the ordinate gives the correspond-
ing values of hydrophobicity (bHN). Thepeptide that ismost internalized is represented in
blue with a gradient to the red for the peptides which are the less internalized. RW16 is
represented in light blue and is well internalized with increasing cytotoxicity.
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RW9, the substitution of Trp by Leu residues has been reported to
remove the cell penetrating ability of the peptide pointing to the impor-
tance of Trp residues [19]. On the contrary, R9 is known as a performing
CPP from previous studies [7,19], leaving open questions on the role of
aromatic residues. The substitution of Trp by Phe residues in the RW9
sequence leads to a major decrease in the cellular internalization,
which was almost abolished for the peptide containing no Trp residues.
In contrast, their membrane accumulation was retained.
Different modes of CPP internalization, direct translocation and
endocytosis, can occur. Direct translocation implies that the peptides
directly reach the cytosol of cells. In contrast, a peptide that enters
through endocytosis, a process that is inhibited at temperatures below
12 °C, ends up into endosomes from which it has to escape to reach
the cytosol of cells. For drug delivery purposes, only the fraction of the
peptide that is not entrapped in endosomes is relevant.
RW9 has been shown previously to enter cells by both direct trans-
location of the plasma membrane and endocytosis [19]. By comparing
RW9 cellular uptake at 4 and 37 °C in wild-type (wt) and GAG-
deﬁcient CHO cells, it was found that 85% of the CPP internalized in wt
cells at 37 °C entered by GAG-dependent endocytosis and 15% by direct
translocation.We observed here that internalization of all the RX9 pep-
tides at 37 °C is extremely low and is in almost all cases decreasedmore
than 10 times compared to RW9. This suggests that both endocytosis
and direct translocation are affected by the replacement of Trp residues
with Phe residues. However, we could not perform internalization
experiments at 4 °Cwith the RX9peptides tomeasure their entry exclu-
sively by direct translocation because as shown, the amounts of inter-
nalized peptide were already quite low at 37 °C. At 4 °C due to
endocytosis blockage, one expects the internalization to be even
lower, as observed for RW9 peptide [19], and therefore impossible to
measure for the RX9 peptides.
The role of Trp residues in the recruitment of cell-surface GAGs to
trigger endocytosis has been investigated before using biophysical
methods [12,52]. In contrast, the implication of this amino acid in direct
translocation is still not fully understood, although Rydberg et al.
have recently highlighted that tryptophan position in dodecapeptide
Arg/Trp sequences affects cytotoxicity and theway these peptides inter-
act with the different model membranes [53,54].
We performed here a complete biophysical study of RW9 and RX9
analogs aimed at correlating their cellular uptake properties to better
understand the role of Trp residues in direct translocation of the plasma
membrane. We showed that in the presence of lipids their secondary
structure was not modiﬁed even if they are mostly unstructured.
Contrarily to what the literature suggests for some CPPs [55], the cellu-
lar internalization of these peptides is not directly correlated to their
secondary structure.
Despite the fact that all peptides accumulate and partition in the
membrane in the same way, we concluded that their anchoring in the
membrane is directly dependent on the hydrophobicity and interfacial
properties of the amino-acids. Arg residues drive their binding to the
membrane and are responsible for their membrane accumulation and
partition, explaining their enhanced interaction with anionic lipids.
Following such interaction, Arg residues play the role of hinge allowing
insertion of the hydrophobic residues more deeply into the membrane.
At this point the nature of the hydrophobic residues is detrimental to
the CPP fate in terms of the reversibility of the membrane interaction
and ultimate membrane crossing. Indeed our studies reveal that less
hydrophobic residues and more interfacial ones will help the peptides
to establish more transitory interactions with the membrane in part
due to a less deep membrane insertion. Such malleable membrane
interaction and peptide structural change are important to avoid the
peptide from being retained in the membrane interior and to trigger
translocation into membranes. This study demonstrates that not only
the number but also the nature and the positioning of the hydrophobic
residues, their aromaticity and interfacial properties are important fortheir membrane translocation. Penetrating properties are favored
when Trp residues form a large hydrophobic peptide face. Additionally,
Trp residues in positions 4 and 7 of the RW9 sequence have been shown
to promote π–cation interactions important to partially mask the
peptide charge and decrease the energy barrier for membrane translo-
cation [19]. Overall, membrane interaction should allow peptide
accumulation but a deep membrane insertion should be avoided in
order to favor more transitory interactions and allow membrane
translocation.
To reinforce this idea, we have calculated the hydrophobic moment
for all RW9 and RX9 peptides, the helical projections of the peptides
were performed (Fig. S5) and a plot representing hydrophobicity vs.
hydrophobic moment of the peptides allowed us to visualize the
differences in terms of hydrophobicity between each peptide (Fig. 6).
Hydrophobic plot indicated that diminution of hydrophobicity and
amphipathicity of the RX9 peptides decreases its cellular uptake and
that the substantial increase of these parameters leads to an increase
of their cytotoxicity. This suggests that a ﬁne tuning of these parameters
exists to enhance CPP internalization and that above this threshold
value toxicity starts to develop.
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